93 related articles for article (PubMed ID: 7930576)
1. The effect of mutant beta 2-microglobulins on the conformation of HLA-B27 detected by antibody and by CTL.
Fukazawa T; Hermann E; Edidin M; Wen J; Huang F; Kellner H; Floege J; Farahmandian D; Williams KM; Yu DT
J Immunol; 1994 Oct; 153(8):3543-50. PubMed ID: 7930576
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
3. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition.
Villadangos JA; Galocha B; López D; Calvo V; López de Castro JA
J Immunol; 1992 Jul; 149(2):505-10. PubMed ID: 1378067
[TBL] [Abstract][Full Text] [Related]
4. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
el-Zaatari FA; Sams KC; Taurog JD
J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
[TBL] [Abstract][Full Text] [Related]
5. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
Villadangos JA; Galocha B; López de Castro JA
J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
[TBL] [Abstract][Full Text] [Related]
6. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
Calvo V; Rojo S; López D; Galocha B; López de Castro JA
J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.
Allen RL; O'Callaghan CA; McMichael AJ; Bowness P
J Immunol; 1999 May; 162(9):5045-8. PubMed ID: 10227970
[TBL] [Abstract][Full Text] [Related]
8. Testing the importance of each residue in a HLA-B27-binding peptide using monoclonal antibodies.
Fukazawa T; Wang J; Huang F; Wen J; Tyan D; Williams KM; Raybourne RB; Yu DT
J Immunol; 1994 Feb; 152(3):1190-6. PubMed ID: 8301123
[TBL] [Abstract][Full Text] [Related]
9. A nucleoprotein peptide of influenza A virus stimulates assembly of HLA-B27 class I heavy chains and beta 2-microglobulin translated in vitro.
Kvist S; Hamann U
Nature; 1990 Nov; 348(6300):446-8. PubMed ID: 2247148
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody that recognizes HLA-B27 in the context of peptides.
Wang J; Yu DT; Fukazawa T; Kellner H; Wen J; Cheng XK; Roth G; Williams KM; Raybourne RB
J Immunol; 1994 Feb; 152(3):1197-205. PubMed ID: 8301124
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of HLA-B27 in lipid-linked form: implications for cytotoxic T lymphocyte-induced apoptosis signal transduction.
Gao XM; Quinn CL; Bell JI; McMichael AJ
Eur J Immunol; 1993 Mar; 23(3):653-8. PubMed ID: 8449213
[TBL] [Abstract][Full Text] [Related]
12. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis.
Ugrinovic S; Mertz A; Wu P; Braun J; Sieper J
J Immunol; 1997 Dec; 159(11):5715-23. PubMed ID: 9548516
[TBL] [Abstract][Full Text] [Related]
13. Peptide presentation to an alloreactive CTL clone is modulated through multiple mechanisms involving polymorphic and conserved residues in HLA-B27.
García-Peydró M; Paradela A; Lamas JR; López De Castro JA
J Immunol; 1999 Dec; 163(11):6060-4. PubMed ID: 10570294
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of the human HLA-A2 or HLA-B7 heavy chain gene and human beta 2-microglobulin gene in L cells.
Bernabeu C; Maziarz R; Spits H; de Vries J; Burakoff SJ; Terhorst C
J Immunol; 1984 Dec; 133(6):3188-94. PubMed ID: 6436376
[TBL] [Abstract][Full Text] [Related]
15. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
Cook JR; Solheim JC; Connolly JM; Hansen TH
J Immunol; 1995 Jan; 154(1):47-57. PubMed ID: 7995959
[TBL] [Abstract][Full Text] [Related]
16. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705.
Villadangos JA; Galocha B; García-Hoyo R; López D; García F; López de Castro JA
Eur J Immunol; 1994 Oct; 24(10):2548-55. PubMed ID: 7523146
[TBL] [Abstract][Full Text] [Related]
17. Association with beta 2-microglobulin controls the expression of transfected human class I genes.
Rein RS; Seemann GH; Neefjes JJ; Hochstenbach FM; Stam NJ; Ploegh HL
J Immunol; 1987 Feb; 138(4):1178-83. PubMed ID: 3543123
[TBL] [Abstract][Full Text] [Related]
18. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
[TBL] [Abstract][Full Text] [Related]
19. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
20. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
Uger RA; Barber BH
J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
